Basel, Switzerland

Paulo Antonio Fernandes Gomes Dos Santos

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 14.9

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovator Spotlight: Paulo Antonio Fernandes Gomes Dos Santos

Introduction: Meet Paulo Antonio Fernandes Gomes Dos Santos, a talented inventor hailing from Basel, Switzerland, with a strong passion for creating innovative solutions in the field of healthcare.

Latest Patents: Paulo Antonio Fernandes Gomes Dos Santos has recently been granted three patents, showcasing his expertise in the medical field. One of his latest patents involves the use of inhibitors of the activity or function of PI3K for the treatment of various immunopathological conditions such as malaria, leishmaniasis, trypanosomiasis, toxoplasmosis, and neurocysticercosis. Another patent highlights tetrahydro-pyrido-pyrimidine derivatives which are effective in treating disorders mediated by the activity of PI3K enzymes.

Career Highlights: Currently affiliated with Novartis AG, a renowned pharmaceutical company, Paulo Antonio Fernandes Gomes Dos Santos continues to make significant contributions to the field of healthcare through his groundbreaking inventions and research.

Collaborations: In his endeavors, Paulo Antonio Fernandes Gomes Dos Santos has collaborated with notable colleagues such as Nigel Graham Cooke and Christina Hebach, bringing together a wealth of expertise and knowledge to drive innovation in the healthcare industry.

Conclusion: Paulo Antonio Fernandes Gomes Dos Santos stands out as a pioneering inventor in the medical field, consistently pushing the boundaries of innovation to develop new treatments and solutions for complex diseases. His dedication to advancing healthcare through his patented inventions is truly commendable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…